Strategic. Insightful. Actionable.

About Darwin Research Group

We are a business strategy and market analytics firm that specializes in healthcare delivery systems. Through consulting services, custom research, and syndicated reports, we empower our clients to engage with an evolving healthcare environment and execute initiatives to move their ventures forward.

    Click to learn more.

    Sectors We Track

    Hospitals and Integrated Health Systems • Accountable Care Organizations • Payers and PBMs • Behavioral Health Care • Home Health Care • Pharmaceuticals and Biotechnology • Medical Devices and MedTech • Institutional and Specialty Pharmacy • Medicare, Medicaid and Health Policy

    News & Analysis

    By the numbers: Proportion of Payments that are Value-Based

    By the numbers: Proportion of Payments that are Value-Based

    Several weeks ago, Darwin CEO John Marchica presented at ExL’s 11th Partnering with ACOs and IDNs Summit. During the conference, one of the presenters suggested that less than 10 percent of payments in the United States were value-based. That seemed low.   We did a little digging into what payers are...

    Read more

    Lowering drug prices: What’s being done, what’s to come (updated)

    When Donald Trump announced his much-anticipated “blueprint” to control prescription drug prices on May 11, he said his administration was “launching the most sweeping action in history to lower the price of prescription drugs for the American people.” The focus appears to be on four general strategies to bring down...

    Read more

    Trump Administration offers proposal to rein in prescription drug prices

    On Friday, President Trump announced a much anticipated “blueprint” to control prescription drug pricing. In his remarks in the White House Rose Garden, Trump said, “The drug lobby is making an absolute fortune at the expense of American consumers.”

    Read more